Oncotarget has recently garnered attention for its research into the harmful affects e-cigarettes can have on a user. Though e-cigarettes are tobacco free, the battery operated device does still contain nicotine and other chemicals that possess the potential to be harmful to the human body. The English journals largest discovery of the study pertained to e-liquid. It had a longtime suspicion that e-liquid caused damage to the mouth, specifically the gum tissue. The study found that many steady users of e-cigarettes experienced inflammation in the gum. E-cigarettes can also act as a catalyst for gum cancer, as they bridge the gap between microorganisms and the mouth.
Led by remarkable chief editors Andrei V. Gudkov and Mikhail Blagosklonny Oncotarget was named the number one ranked publication by Thomson Reuters JCR Impact Factor in 2011 and it has held that ranking since. Editors Andrei V. Gudkov and Mikhail Blagosklonny are widely considered as two of the best in their chosen profession. Check Oncotarget at scimagojr.com
At the very beginning Oncotarget was created with the intention of becoming a leading publication, educating people on exclusively oncology. Because of the journal’s exponential growth since it was founded in 2010, it became more diverse and started covering non-oncological health matters.
About Mikhail Blagosklonny
Mikhail Blagosklonny has built a name for himself in the world of oncology. He specializes in studying how the human body effects aging and cancer. He received his M.D. in internal medicine and his PhD in experimental medicine and cardiology from the First Pavlov State Medical University of St. Petersburg.
The oncologist has been a long time public supporter of Rapamycin, a popular cancer drug. Blagosklonny has always believed aging and cancer can be held in check if the right individuals work towards finding a solution. He currently serves as chief editor at Roswell Park Institute.